The cosmetics giant identified a tendency for people experiencing seborrheic dermatitis to also experience hair loss.
Cosmax researchers investigated the relationship between scalp microbiota and these conditions.
The study compared groups of individuals with male and female pattern hair loss to a control group with healthy scalps.
It analysed microbial distribution, diversity, function, and metabolic pathways.
By analysing the microorganisms around hair follicles, they identified microbial differences between healthy scalps and those with hair loss.
Researchers found that individuals with hair loss exhibited lower microbial diversity, a reduced presence of microbes responsible for hair acidification, which is a key process for that ensures a healthy scalp pH.
Additionally, it observed suppressed lipid metabolism pathways that regulate sebum production.
Based on these insights, the researchers concluded that an imbalanced scalp microbiome played a significant role in the onset of hair loss and seborrheic dermatitis.
Dual action scalp care
This led to the development of Dandriome, which the firm claims can address both hair loss and seborrheic dermatitis simultaneously.
The ingredient was developed by studying the beneficial microorganisms found in healthy scalps.
According to the firm, Dandriome can suppress lipid production factors to reduce excess oil on the scalp.
It can also inhibit hyperkeratosis – the thickening of the skin’s outer layer linked to flaking and scaling – at a cellular level.
The active was found to reduce the biofilm and biomass of Malassezia, a yeast that overgrows on the scalp and is known to be a key contributing factor of seborrheic dermatitis.
Regarding hair loss, the firm claims that Dandriome could influence the activity and growth factors of dermal papilla cells.
This suggesting a potential benefit in alleviating hair loss symptoms.
“The newly developed ingredient is an innovative solution that can simultaneously address two major concerns related to the scalp and hair: hair loss and seborrheic dermatitis. We will continue to expand research into microbiome-based solutions to lead the global market with cutting-edge materials and product development,” the firm said.
The company added that it attended the International Society of Hair Restoration Surgery (ISHRS) conference held in Denver, USA, last October, where it showcased its latest advancements.
Additionally, the presented research on hair organoids developed with Organoid Science, which won first place in the 2024 Cases, Studies, and Innovations category.
The research, which uses hair organoid technology to evaluate male pattern baldness, also validated the effectiveness of SoyAct, a proprietary ingredient from Cosmax derived from soybean.
According to the firm, the result positioned SoyAct as a promising solution for hair efficacy evaluation and the hair transplantation market.
